Price T Rowe Associates Inc Pulmonx Corp Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 42,709 shares of LUNG stock, worth $354,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,709
Previous 35,720
19.57%
Holding current value
$354,057
Previous $332,000
18.37%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LUNG
# of Institutions
116Shares Held
30.6MCall Options Held
400Put Options Held
0-
Primecap Management CO Pasadena, CA5.71MShares$47.3 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.47MShares$28.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$22.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$18 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M1.29MShares$10.7 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $309M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...